Cargando…

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

Mature B cell neoplasms, previously indolent non-Hodgkin lymphomas (iNHLs), are a heterogeneous group of malignancies sharing similar disease courses and treatment paradigms. Most patients with iNHL have an excellent prognosis, and in many, treatment can be deferred for years. However, some patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lumish, Melissa, Falchi, Lorenzo, Imber, Brandon S., Scordo, Michael, von Keudell, Gottfried, Joffe, Erel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789477/ https://www.ncbi.nlm.nih.gov/pubmed/33407745 http://dx.doi.org/10.1186/s13045-020-01018-6

Ejemplares similares

P1220: EXPLORING TP53 BIOLOGY IN DIFFUSE LARGE B-CELL LYMPHOMA: A GENOMIC AND TRANSCRIPTOMIC META-ANALYSIS
por: Uppal, Manik, et al.
Publicado: (2023)

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms
por: Kutsch, Nadine, et al.
Publicado: (2015)

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
por: Imber, Brandon S., et al.
Publicado: (2021)

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas
por: Gunnellini, Marco, et al.
Publicado: (2012)

The role of tazemetostat in relapsed/refractory follicular lymphoma
por: von Keudell, Gottfried, et al.
Publicado: (2021)

Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study
por: Qi, Shunan, et al.
Publicado: (2022)

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
por: Bobillo, Sabela, et al.
Publicado: (2021)

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas
por: Arcaini, Luca, et al.
Publicado: (2012)

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms
por: Fernández-Garnacho, Elena María, et al.
Publicado: (2023)

Rare concurrent indolent B-cell lymphoma and plasmablastic transformation of myeloma
por: Saburi, Masuho, et al.
Publicado: (2018)

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022)

Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
por: Menzer, Christian, et al.
Publicado: (2022)

Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms
por: Dumontet, Erwan, et al.
Publicado: (2021)

Indolent T‐cell‐rich small B‐cell hepatic lymphoma in a Golden Retriever
por: Rout, Emily D., et al.
Publicado: (2018)

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
por: Merli, Michele, et al.
Publicado: (2016)

Mature B‐cell lymphomas in adolescents and young adults
por: El‐Mallawany, Nader Kim, et al.
Publicado: (2023)

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
por: Batlevi, Connie L., et al.
Publicado: (2020)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
por: Ott, German, et al.
Publicado: (2009)

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
por: Blix, Egil S, et al.
Publicado: (2012)

Light Chain Crystal Podocytopathy in a Patient With Systemic Indolent B-Cell Lymphoma
por: Kamar, Fareed, et al.
Publicado: (2019)

The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas
por: Artemaki, Pinelopi I., et al.
Publicado: (2021)

Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features
por: Lim, Sojung, et al.
Publicado: (2022)

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma
por: Daniel, Adrien, et al.
Publicado: (2022)

A modular transcriptome map of mature B cell lymphomas
por: Loeffler-Wirth, Henry, et al.
Publicado: (2019)

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
por: Sha, Fushen, et al.
Publicado: (2022)

Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
por: Lin, Yi, et al.
Publicado: (2014)

Indolent T-cell lymphoproliferative disease with synchronous diffuse large B-cell lymphoma: A case report
por: Guo, Linjie, et al.
Publicado: (2019)

Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation
por: Arboe, Bente, et al.
Publicado: (2017)

Detection of cytogenetic abnormalities in mature B-cell neoplasms: the value of cultures with different mitogens
por: da Silva Oliveira, Roberta Maria, et al.
Publicado: (2014)

CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms
por: Fouad, Neveen Bahaa El Din, et al.
Publicado: (2018)

Expression of TRPM8 in human reactive lymphoid tissues and mature B-cell neoplasms
por: Hirai, Akinori, et al.
Publicado: (2018)

Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma
por: Takahashi, Naoki, et al.
Publicado: (2021)

Successful Treatment of Leukemic Mature B-Cell Lymphoid Neoplasm with Similar Features to Splenic Marginal Zone Lymphoma Possessing Aberrant Myeloid Markers
por: Imashuku, Shinsaku, et al.
Publicado: (2015)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
por: Saito, H, et al.
Publicado: (2015)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
por: Saito, H, et al.
Publicado: (2017)

Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice
por: Vincent-Fabert, Christelle, et al.
Publicado: (2019)

Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
por: Crisci, Stefania, et al.
Publicado: (2019)

PB1919: MATURE B-CELL NEOPLASMS CD5 NEGATIVE: CONFRONTATION CYTOMETRY-CYTOLOGY
por: Cheikh, Hanen Ben, et al.
Publicado: (2023)

Development of diffuse large B-cell lymphoma in a patient with Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms
por: Shiseki, Masayuki, et al.
Publicado: (2011)

Function of B-Cell CLL/Lymphoma 11B in Glial Progenitor Proliferation and Oligodendrocyte Maturation
por: Wang, Chih-Yen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hplirep4niqv13toc1f1ir9f8d